FMCG major reports high single-digit growth in India as Dettol and Durex lead volume gains amid GST changes
British consumer goods company Reckitt reported steady momentum in India during the third quarter of 2025, despite temporary disruptions from the implementation of new GST slabs in September. The company said like-for-like (LFL) net revenue growth in India remained in the high single digits for the year to date.
Key categories such as Germ Protection and Intimate Wellness performed well, led by Dettol, Harpic, and Durex. Reckitt said volume-led growth in Dettol helped achieve double-digit growth in the quarter, while Durex continued to gain market share in India.
Globally, Reckitt delivered a solid performance with group LFL net revenue up 7 per cent in Q3, supported by Core Reckitt and a 22 per cent increase in Mead Johnson Nutrition. Emerging Markets led growth, offsetting softness in developed markets. Reckitt’s Emerging Markets portfolio posted 15.5 per cent LFL growth in the quarter.
“We have delivered a strong third-quarter performance with LFL net revenue up 6.7% in Core Reckitt. These results reflect sequential volume improvements and the strength of our Powerbrands. We returned to growth in Developed Markets against a challenging consumer landscape and continued to deliver outsized growth in Emerging Markets ”, said Kris Licht, Chief Executive Officer, Reckitt Benckiser.
Reckitt operates in India with power brands including Lysol, Vanish, Strepsils, Veet, Dettol, Harpic, and Durex. Leading FMCG companies in India faced temporary trade channel disruptions in September following the government’s Next-Generation GST reforms, which lowered duties on most daily essentials, including food and personal care products, to a 5 per cent slab.
For Q3, Reckitt reported total group net revenue of 3,611 million British Pounds, with a 4.2 per cent volume growth. In emerging markets, net revenue reached 1,080 million British Pounds, up 15.5 per cent.
